All resources

In November 2023, we responded to the Government's consultation on the introduction of Mandatory Reporting of Child Sexual Abuse. This followed our response in August 2023 to the Government's call for evidence on Mandatory Reporting. We were disappointed to see an absence of acknowledgement in the m...

Published in December 2023, this clinical practice guideline developed by RCPCH and the Neonatal and Paediatric Pharmacy Group Joint Standing Committee on Medicines (RCPCH-NPPG), covers the inclusion of medication analysis in the paediatric ward round environment to improve medication safety.

The law in the UK was changed in November 2018 to make prescribing of medical cannabis legal, but parents have been struggling to secure prescriptions. For parents whose children have a condition for which they feel medicinal cannabis is helping, not having the medicine readily available is incredib...

This committee regularly responds to consultations from government organisations and public bodies such as the National Institute of Clinical Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN).

Medication errors are a significant but preventable cause of harm to children and young people. Meds IQ brings together quality improvement (QI) tools and improvement projects that have been developed to address this problem. This is part of QI Central, our quality improvement sharing platform, whic...

Medusa provides guidance on the preparation and administration of injectable medicines in adult and paediatric clinical areas with links, if appropriate, to local practice guidelines. It contains over 400 monographs for medicines given via the intravenous (IV) route.

On 31 October 2021, the National Institute for Health and Care Excellence (NICE) published an updated version of the ME/CFS clinical guideline. The RCPCH consulted on the guideline and met with NICE as they worked with patient groups and representative organisations to finalise the guideline. This b...